DDR CEO invited as Regulatory Expert on Catalan TV
DDR’s CEO Xavier Luria was special guest on TV3 program “Tot es mou” this Monday 08 February 2021. He was invited to share his thoughts on 2021’s big question: How reliable is the homologation of COVID-19 vaccines in Europe?
Dr Luria was Head of Safety and Efficacy of Medicines at the European Medicines Agency (EMA) 2005-2012, where he coordinated regulatory teams from the 28 European Member States in order to evaluate medicinal products for the whole European Union.Dr. Luria was in charge of several cross-agency projects, including implementation of electronic submissions using eCTD and the development of other IT tools, review and reorganization of CHMP’s Working Parties, coordination and expansion of the EMA’s Scientific Advisory Groups (SAG), and new methodologies on Benefit/Risk assessment.
Watch the replay (Catalan)